Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Homeopathic drug C12 · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Homeopathic drug, potency C12 | EXPERIMENTAL | - |
| Placebo | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Homeopathic drug C12 | DRUG | Subjects in the intervention group are instructed to take five globules of the trial drug (potency C12), five times per day for a maximum of five days (5×5×5). The study medication is obtained from DHU (Germany), produced according to the Hahnemannian method. Subjects are asked to stop taking the medication, in agreement with their investigator, if they experience any of a predefined set of proving symptoms |
| Placebo | OTHER | Placebo consists of pure sucrose globules (DHU, Germany) that are not potentiated nor impregnated with alcohol. The administration scheme is identical in the placebo control group to that of the intervention group. |
Inclusion Criteria: * Medical doctors or medical students * Not being treated for any acute or chronic diseases on the day of inclusion * Written informed consent. Exclusion Criteria: * Pregnant women or nursing mothers * Homeopathic treatment over the previous six weeks * Participation in anothe...